ask="1.88"
ask_size="200"
average_daily_volume="135092"
bid="1.14"
bid_size="900"
book_value="0.33"
change="-0.00"
change_from_200_day_moving_average="-0.42"
change_from_50_day_moving_average="-0.01"
change_from_52_week_high="-2.26"
change_From_52_week_low="0.41"
change_in_percent="-0.41%"
close="1.22"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.81"
ebitda="-19.61M"
eps_estimate_current_year="-0.72"
eps_estimate_next_quarter="-0.15"
eps_estimate_next_year="-0.62"
ex_dividend_date="N/A"
float_shares="25237000"
high="1.27"
high_52_weeks="3.48"
last_trade_date="3/10/2017"
last_trade_price="1.22"
last_trade_size="1933"
last_trade_time="4:00pm"
low="1.21"
low_52_weeks="0.81"
market_capitalization="31.02M"
moving_average_200_day="1.64"
moving_average_50_day="1.23"
name="Repros Therapeutics Inc."
notes="N/A"
one_year_target_price="5.25"
open="1.25"
pe_ratio="N/A"
peg_ratio="-0.06"
percent_change_from_200_day_moving_average="-25.71%"
percent_change_from_50_day_moving_average="-0.56%"
percent_change_from_52_week_high="-64.94%"
percent_change_from_52_week_low="+50.62%"
previous_close="1.23"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.68"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="25425000"
short_ratio="3.89"
stock_exchange="NCM"
symbol="RPRX"
volume="86078"
weeks_range_52="0.81 - 3.48"
